HIV gp120 (421-438)

OC(C=C1)=CC=C1C[C@@H](C(N[C@@H](C)C(N2[C@@H](CCC2)C(N3[C@@H](CCC3)C(O)=O)=O)=O)=O)NC([C@H](CCSC)NC([C@H](C)NC([C@H](CCCCN)NC(CNC([C@H](C(C)C)NC([C@H](CCC(O)=O)NC([C@H](CCC(N)=O)NC([C@@H](NC([C@H](CCSC)NC([C@H](CC(N)=O)NC([C@H]([C@@H](C)CC)NC([C@@H](NC([C@H](CCC(N)=O)NC([C@@H](N)CCCCN)=O)=O)CC4=CC=CC=C4)=O)=O)=O)=O)CC5=CNC6=CC=CC=C56)=O)=O)=O)=O)=O)=O)=O)=O

[1]Justiz-Vaillant A, et al., In vivo administration of anti-HIV hyper-immune eggs induces anti-anti-idiotypic antibodies against HIV gp120 peptides (fragments 308-331 and 421-438) and against HIV gp41 peptide (fragment 579-601) which have demonstrable protective capacity[J]. bioRxiv, 2021: 2021.05. 02.442298.